Inventor · disambiguated record
Baoqing Gong
Also filed as: GONG BAOQING
18 granted patents·10 pending applications·208 citations·filing 1995–2019
94Inventor score
Files withCELL THERAPEUTICS INC14CALIENNI JOHN VINCENT5CAPACCI-DANIEL CHRISTINA2FENG LILI2NOVARTIS AG2
Top patents by PatentIndex Score
28 records- 0196US7618968B2Aryl triazines as LPAAT-β inhibitors and uses thereofCELL THERAPEUTICS INC·Filed 2007·Granted Nov 17, 2009·24 cites·12 claims
- 0295US6878715B1Therapeutic compounds for inhibiting interleukin-12 signals and method for using sameCELL THERAPEUTICS INC·Filed 2000·Granted Apr 12, 2005·46 cites·6 claims
- 0392US9193732B2Salt(s) of 7-cyclopentyl-2-(5-piperazin-1-yl-pyridin-2-ylamino)-7H-pyrrolo[2,3-D]pyrimidine-6-carboxylic acid dimethylamide and processes of making thereofCALIENNI JOHN VINCENT·Filed 2011·Granted Nov 24, 2015·29 cites·9 claims
- 0490US9868739B2Salt(s) of 7-cyclopentyl-2-(5-piperazin-1-yl-pyridin-2-ylamino)-7H-pyrrolo[2,3-d]pyrimidine-6-carboxylic acid dimethylamide and processes of making thereofCALIENNI JOHN VINCENT·Filed 2015·Granted Jan 16, 2018·11 cites·19 claims
- 0589US7419984B2Pyrimidines and uses thereofCELL THERAPEUTICS INC·Filed 2003·Granted Sep 2, 2008·26 cites·12 claims
- 0687US7291616B2Aryl triazines as LPAAT-β inhibitors and uses thereofCELL THERAPEUTICS INC·Filed 2002·Granted Nov 6, 2007·26 cites·2 claims
- 0777US9309229B2Crystalline forms of 5-chloro-N2-(2-isopropoxy-5-methyl-4-piperidin-4-yl-phenyl)-N4-[2-(propane-2-sulfonyl)-phenyl]-pyrimidine-2, 4-diamineFENG LILI·Filed 2011·Granted Apr 12, 2016·3 cites·26 claims
- 0876US7608620B2LPAAT-β inhibitors and uses thereofCELL THERAPEUTICS INC·Filed 2006·Granted Oct 27, 2009·1 cites·8 claims
- 0973US6586429B2Tricyclic fused xanthine compounds and their usesCELL THERAPEUTICS INC·Filed 2000·Granted Jul 1, 2003·6 cites·8 claims
- 1068US8987459B2Compounds for the treatment of conditions associated with DGAT1 activityCAPACCI-DANIEL CHRISTINA·Filed 2014·Granted Mar 24, 2015·2 cites·3 claims
- 1168US2010189726A1Lpaat-beta inhibitors and uses thereofCELL THERAPEUTICS INC·Filed 2009·Application pending·0 cites
- 1266US7064125B2LPAAT-β inhibitors and uses thereofCELL THERAPEUTICS INC·Filed 2003·Granted Jun 20, 2006·2 cites·9 claims
- 1366US6774130B2Therapeutic compounds for inhibiting interleukin-12 signaling and methods for using sameCELL THERAPEUTICS INC·Filed 1999·Granted Aug 10, 2004·22 cites·26 claims
- 1460US2009099183A1Pyrimidines and uses thereofCELL THERAPEUTICS INC·Filed 2008·Application pending·0 cites
- 1559US2015099760A1Salt(s) of 7-cyclopentyl-2-(5-piperazin-1-yl-pyridin-2-ylamino)-7h-pyrrolo[2,3-d]pyrimidine-6-carboxylic acid dimethylamide and processes of making thereofCALIENNI JOHN VINCENT·Filed 2014·Application pending·0 cites
- 1657US7199238B2LPAAT-β inhibitors and uses thereofCELL THERAPUETICS INC·Filed 2005·Granted Apr 3, 2007·0 cites·7 claims
- 1754US2005032748A1Therapeutic compounds for inhibiting interleukin-12 signaling and methods for using sameCELL THERAPEUTICS INC·Filed 2004·Application pending·0 cites
- 1853US2012115878A1Salt(s) of 7-cyclopentyl-2-(5-piperazin-1-yl-pyridin-2-ylamino)-7h-pyrrolo[2,3-d]pyrimidine-6-carboxylic acid dimethylamide and processes of making thereofCALIENNI JOHN VINCENT·Filed 2011·Application pending·0 cites
- 1952US7247630B2Uses of tricyclic compoundsCELL THERAPEUTICS INC·Filed 2003·Granted Jul 24, 2007·0 cites·5 claims
- 2051US2005049262A1Therapeutic compounds for inhibiting interleukin-12 signaling and methods for using sameCELL THERAPEUTICS INC·Filed 2004·Application pending·0 cites
- 2149US9359326B2Manufacturing process for pyrimidine derivativesCALIENNI JOHN VINCENT·Filed 2015·Granted Jun 7, 2016·0 cites·2 claims
- 2249US6194421B1Inhibitors of metazoan parasite proteasesUNIV CALIFORNIA·Filed 1997·Granted Feb 27, 2001·9 cites·8 claims
- 2348US2003100557A1LPAAT-beta inhibitors and uses thereofCELL THERAPEUTICS INC·Filed 2002·Application pending·0 cites
- 2443US2016175305A1Crystalline forms of 5-chloro-n2-(2-isopropoxy-5-methyl-4-piperidin-4-yl-phenyl)-n4-[2-(propane-2-sulfonyl)-phenyl]-pyrimidine-2, 4-diamineFENG LILI·Filed 2016·Application pending·0 cites
- 2541US2020039935A1Chemical Process for Preparing Pyrimidine Derivatives and Intermediates ThereofNOVARTIS AG·Filed 2019·Application pending·0 cites
- 2640US9242971B2Compounds for the treatment of conditions associated with DGAT1 activityCAPACCI-DANIEL CHRISTINA·Filed 2015·Granted Jan 26, 2016·0 cites·17 claims
- 2735US5739170AInhibitors of metazoan parasite proteasesUNIV CALIFORNIA·Filed 1995·Granted Apr 14, 1998·1 cites·9 claims
- 2828US2018057457A1Chemical Process for Preparing Pyrimidine Derivatives and Intermediates ThereofNOVARTIS AG·Filed 2015·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Baoqing Gong files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →